About
Profile Summary
Dr. Sreejith Raveendran is a Senior Lecturer in Biotechnology at Teesside University, leading the NanoSree Lab and specializing in nanomedicine, targeted cancer therapies, and bio-nanotechnological innovations. His academic roles include teaching modules like Advanced Upstream Bioprocessing and Cancer Diagnostics, alongside postgraduate supervision.
Education & Career
He earned a PhD in Bionanoscience from Toyo University (Japan) in 2013. His career includes postdoctoral fellowships at IIT Delhi, University of Brighton (UK), and Toyo University, focusing on nanovector design for combinatorial cancer therapies. Key roles include:
- Marie Sklodowska Curie Actions (MSCA) Fellowship (2016-2019) for glioblastoma research
- MEXT-Japan Fellowship (2010-2013) for extremophilic polysaccharide research
Research Interests
His research integrates nanotechnology with cancer biology, emphasizing:
- Targeted drug delivery via smart nanovectors
- Theranostic systems for early cancer detection and treatment
- Bio-inspired materials (e.g., extremophilic polysaccharides)
- Combination therapies for glioblastoma and endocrine cancers
Awards & Recognition
- Young Scientist Medal (2018)
- Science Excellence Award (2020)
- Recipient of major grants from EU (MSCA), Alzheimer’s Research UK, and Teesside University
Collaborations & Outreach
He collaborates with industry partners like Thermo Scientific and JEOL Japan, and serves on the Research Advisory Board at IQRAA Hospital (India). His editorial roles include Special Issue Editor for Pharmaceutics and Processes.
Labs & Teams
As NanoSree Lab Group Leader, he oversees projects on cellular dynamics, autophagy, and biosensor development. The lab focuses on translating nanotechnology into clinical applications for personalized cancer therapies.
